We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Predicting Response and Toxicity in Patients Receiving Lonafarnib for Breast Cancer

This study has been terminated.
(funding terminated)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01232881
First Posted: November 2, 2010
Last Update Posted: April 28, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
United States Department of Defense
Indiana University School of Medicine
Emory University
Information provided by:
Hoosier Cancer Research Network
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2010
  Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)